GT Biopharma, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2015 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
GT Biopharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2015 to 2023.
  • GT Biopharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 2.23M shares, a 63.4% increase year-over-year.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.35M shares, a 26.9% increase from 2022.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.06M shares.
  • GT Biopharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 4.39M shares, a 29.6% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 1.35M +285K +26.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 1.06M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2020 4.39M +1M +29.6% Jan 1, 2020 Dec 31, 2020 10-K 2021-04-16
2019 3.38M +3.33M +6636% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-16
2018 50.2K +33.5K +200% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-27
2017 16.8K -64.7K -79.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 81.5K -2.31M -96.6% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 2.39M Jan 1, 2015 Dec 31, 2015 10-K/A 2018-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.